$ORGO
Organogenesis Holdings Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.795
▼After hours-5.35%-$0.045After hours
Organogenesis Holdings Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ORGO down today? It is at $0.795 (-8.62%), and our scanner flagged it 54 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ORGO spikes, and full due diligence on ORGO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ORGO 54 times in the last 30 days. Create a free account to track $ORGO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ORGO from our scanner (live price and day move above). Fresh from the SEC: Organogenesis Holdings Inc.: Q3 FY2026 results, three months to Sep 30, 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystOrganogenesis Holdings Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from the latest SEC filing. Read it →Across every filing on file, supply equal to 57.2% of the tradeable float is in play - 57.2% more can still be issued.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
31,645,570 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $75.0M in size · Priced at $2.37/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Driscoll Michael Joseph Director | Bought (open market) | +10K | added 4.6% | 226K | $27K at $2.67 | Mar 9, 26 |
Leibowitz Arthur S Director | Bought (open market) | +5K | added 1.7% | 291K | $13K at $2.68 | Mar 9, 26 |
Cavorsi Robert Officer | Sold (automatic/other) | -700 | sold 0.3% | 276K | $2K at $3.21 | Mar 1, 26 |
Korfin Michele Ilene Director | Acquired (grant/award) | +49K 0.04% of company | added 26% | 239K | n/a | Feb 18, 26 |
Lustig Garrett Director | Acquired (grant/award) | +49K 0.04% of company | added 63% | 126K | n/a | Feb 18, 26 |
Duraibabu Prathyusha Director | Acquired (grant/award) | +49K 0.04% of company | added 25% | 247K | n/a | Feb 18, 26 |
Quintero Gilberto Director | Acquired (grant/award) | +49K 0.04% of company | added 26% | 239K | n/a | Feb 18, 26 |
Montecalvo Antonio S. Officer | Acquired (grant/award) | +52K 0.04% of company | added 29% | 230K | n/a | Feb 18, 26 |
Montecalvo Antonio S. Officer | Sold (automatic/other) | -4K | sold 1.6% | 226K | $14K at $3.84 | Feb 18, 26 |
Leibowitz Arthur S Director | Acquired (grant/award) | +49K 0.04% of company | added 21% | 286K | n/a | Feb 18, 26 |
Giacomin Jon L Director | Acquired (grant/award) | +49K 0.04% of company | added 25% | 241K | n/a | Feb 18, 26 |
Driscoll Michael Joseph Director | Acquired (grant/award) | +49K 0.04% of company | added 29% | 216K | n/a | Feb 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ORGO from our scanner (live price and day move above). Fresh from the SEC: Organogenesis Holdings Inc.: Q3 FY2026 results, three months to Sep 30, 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
ORGO last traded at $0.795, down 8.62% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ORGO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ORGO 54 times in the last 30 days.
ORGO (Organogenesis Holdings Inc. Class A Common Stock) trades on XNAS, with a market cap of about $108M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ORGO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ORGO discussion
Sign in to ask a question or join the discussion.